RPS18A Antibody

What is RPS18 and why is it significant in research?

RPS18 (ribosomal protein S18) is a component of the small 40S ribosomal subunit within the larger ribonucleoprotein complex responsible for cellular protein synthesis . It is encoded by the RPS18 gene (NCBI Gene ID: 6222) and produces a 152 amino acid protein with a calculated molecular weight of approximately 18 kDa . The protein is also known by several alternative names including D6S218E, small ribosomal subunit protein uS13, 40S ribosomal protein S18, Ke-3, and Ke3 .

RPS18 is significant in research due to its essential role in translation and has been implicated in various cellular processes beyond protein synthesis. Studies examining ribosome biogenesis, translational regulation, and extraribosomal functions of ribosomal proteins frequently utilize RPS18 antibodies to elucidate these mechanisms.

What types of RPS18 antibodies are currently available for research?

Most commercially available RPS18 antibodies are polyclonal antibodies raised in rabbits. Based on current product information, these antibodies typically target specific epitopes within the human RPS18 protein. Available formulations include:

• Rabbit polyclonal antibodies targeting recombinant fragment proteins within human RPS18 amino acids 50-150

• Rabbit polyclonal antibodies generated against RPS18 fusion proteins

• Unconjugated antibody preparations for maximum application flexibility

These antibodies generally display cross-reactivity with RPS18 from multiple species, particularly human, mouse, and rat samples, making them versatile tools for comparative research .

What applications are RPS18 antibodies validated for?

RPS18 antibodies have been validated for several key applications in molecular and cellular biology research:

When selecting an antibody for a specific application, researchers should consult the product documentation for the specific validation tests performed and optimal working conditions.

How should I optimize RPS18 antibody concentration for Western blotting?

When optimizing RPS18 antibody concentration for Western blotting, follow this methodological approach:

• Begin with a titration experiment using the manufacturer's recommended dilution range (typically 1:500-1:3000) across multiple protein concentrations.

• Prepare a dilution series (e.g., 1:500, 1:1000, 1:2000, 1:3000) and apply to identical Western blot membranes loaded with your samples of interest.

• Evaluate signal-to-noise ratio for each dilution. The optimal concentration should provide clear detection of the 18 kDa band with minimal background.

• Consider the following optimization parameters:

  • Primary antibody incubation time (typically 1-2 hours at room temperature or overnight at 4°C)

  • Blocking buffer composition (5% non-fat dry milk or BSA)

  • Washing stringency (TBST or PBST buffer composition and washing duration)

• Document the optimized protocol thoroughly, as RPS18 detection may require specific considerations depending on cell/tissue type and experimental conditions.

What are the best practices for using RPS18 antibodies in immunofluorescence?

For optimal immunofluorescence results with RPS18 antibodies, consider these research-validated practices:

• Fixation and Permeabilization: Based on published protocols, use paraformaldehyde (PFA) fixation followed by Triton X-100 permeabilization. An example protocol includes 4% PFA fixation and 0.1% Triton X-100 permeabilization as demonstrated in studies examining ribosomal protein localization .

• Antibody Concentration: Start with 4 μg/ml concentration as referenced in successful immunofluorescent analysis of SK-MEL-30 cells , then adjust based on signal intensity and specificity.

• Controls: Include appropriate controls:

  • Primary antibody omission control to assess secondary antibody specificity

  • Blocking peptide competition assay to verify antibody specificity

  • Cell lines with RPS18 knockdown/knockout as negative controls

• Co-localization Studies: Consider co-staining with markers of nucleoli (where ribosome biogenesis occurs) or cytoplasmic ribosome markers to confirm the expected subcellular localization pattern.

• Signal Amplification: If signal intensity is low, consider using a biotin-streptavidin amplification system or a higher sensitivity detection system.

How can I validate the specificity of an RPS18 antibody?

Thorough validation of RPS18 antibody specificity is critical for reliable experimental results. Implement this comprehensive validation workflow:

• Western Blot Analysis: Confirm detection of a single band at the expected molecular weight of 18 kDa across multiple cell types/tissues. Compare with validated RPS18 antibodies from different sources or clones.

• Recombinant Protein Controls: Use purified recombinant RPS18 protein as a positive control and non-related ribosomal proteins as negative controls.

• Genetic Approaches:

  • Perform siRNA or CRISPR/Cas9-mediated knockdown/knockout of RPS18 and verify reduction/absence of signal

  • Express tagged versions of RPS18 and confirm co-localization with antibody staining

• Immunoprecipitation-Mass Spectrometry: Perform IP with the RPS18 antibody followed by mass spectrometry analysis to confirm pull-down of RPS18 and expected interacting partners.

• Cross-Reactivity Assessment: Test antibody reactivity against closely related ribosomal proteins, particularly those with similar sequences that might cross-react.

How can RPS18 antibodies be used to study ribosome biogenesis disorders?

RPS18 antibodies serve as valuable tools for investigating ribosome biogenesis disorders through several approaches:

• Nucleolar Stress Response: Monitor RPS18 localization changes during nucleolar stress, which often indicates dysregulation of ribosome assembly. Immunofluorescence with RPS18 antibodies can reveal abnormal nucleolar morphology or protein redistribution.

• Ribosomal Protein Imbalance: Quantify RPS18 levels in cellular models of ribosomopathies using Western blotting with standardized protocols (1:1000 dilution recommended) to assess disruption in stoichiometric balance of ribosomal proteins .

• Pre-rRNA Processing Analysis: Combine RPS18 antibodies with RNA immunoprecipitation (RIP) assays to investigate aberrant pre-rRNA processing, a hallmark of many ribosome biogenesis disorders.

• Protein-Protein Interaction Studies: Employ co-immunoprecipitation with RPS18 antibodies to identify altered interactions within the small ribosomal subunit assembly pathway.

• Tissue-Specific Expression: Analyze tissue-specific expression patterns of RPS18 in patient samples using immunohistochemistry to correlate with disease phenotypes.

When studying rare ribosomopathies, careful antibody validation is especially critical to distinguish between direct disease effects and secondary adaptations.

What methodological considerations exist when studying RPS18 in the context of virus-host interactions?

Recent research has revealed interesting roles for ribosomal proteins, including RPS18, in virus-host interactions, particularly in RNA virus infections. When investigating these relationships:

• Infection Time Course Analysis: Design experiments with multiple timepoints to capture dynamic changes in RPS18 expression and localization during viral infection. Studies have shown that antibody-dependent dengue virus entry modulates host cell intrinsic responses, including effects on ribosomal gene expression .

• Viral Antigen Co-localization: Combine RPS18 antibody staining with viral antigen detection to assess potential co-localization or sequestration of ribosomal components during infection.

• Cell Sorting Approaches: Consider FACS-based approaches to isolate infected cells with equivalent viral antigen loads when comparing different infection conditions, similar to methodologies used in dengue virus research .

• Host Dependency Factor Assessment: Investigate whether RPS18 functions as a host dependency factor for viral replication. Studies have identified that certain ribosomal proteins are uniquely upregulated during antibody-dependent enhancement (ADE) of dengue virus infection .

• Control for Infection-Induced Translational Changes: Include appropriate controls to distinguish between specific effects on RPS18 and global translational reprogramming often induced by viral infection.

What are the considerations when differentiating between RPS18 isoforms or variants?

Differentiating between potential RPS18 isoforms or variants requires careful antibody selection and experimental design:

• Epitope Mapping: Determine precisely which epitope(s) your antibody recognizes. The information that some antibodies target amino acids 50-150 of human RPS18 is crucial for predicting which isoforms will be detected.

• Isoform-Specific Detection Strategies:

  • Utilize antibodies raised against unique regions that differ between isoforms

  • Combine with RT-PCR using isoform-specific primers to correlate protein and mRNA expression

  • Consider 2D gel electrophoresis followed by Western blotting to separate isoforms based on both molecular weight and isoelectric point

• Recombinant Protein Standards: Generate recombinant proteins representing each isoform as standards for antibody specificity testing.

• Post-Translational Modification Analysis: Be aware that some apparent isoforms may represent differently modified forms of the same protein. Consider phosphatase or deglycosylation treatments prior to analysis.

• Species-Specific Considerations: Note that antibody cross-reactivity between species (human, mouse, rat) may complicate isoform detection if species-specific variants exist.

How should I address inconsistent results when using RPS18 antibodies in different cell types?

When encountering variability in RPS18 antibody performance across different cell types:

• Cell Type-Specific Expression Levels: Quantify baseline RPS18 expression levels in each cell type using qPCR to determine if expression differences might explain variable antibody performance.

• Protocol Optimization Matrix: Systematically test multiple parameters for each cell type:

  Parameter	Variables to Test
  Fixation	Duration (10-30 min), temperature, fixative concentration
  Permeabilization	Detergent type (Triton X-100, saponin), concentration (0.1-0.5%), incubation time
  Blocking	Serum type, BSA percentage (1-5%), blocking duration
  Antibody concentration	Titration series specific to each cell type

• Cell-Specific Background Reduction: For high-background cell types, consider:

  • Additional washing steps

  • Including 0.1-0.3M NaCl in washing buffer to reduce non-specific ionic interactions

  • Pre-adsorption of primary antibody with cell lysate from a non-expressing control

• Positive Controls: Include a known high-expressing cell line (e.g., SK-MEL-30 for immunofluorescence) as a positive control in each experiment.

• Alternative Antibody Clones: Test multiple antibodies targeting different epitopes within RPS18 to identify the most consistent performer across your cell types of interest.

What storage and handling practices ensure optimal RPS18 antibody performance?

Proper storage and handling of RPS18 antibodies is essential for maintaining reactivity and specificity:

• Storage Conditions: Store antibodies at -20°C in accordance with manufacturer recommendations. Products are typically stable for one year after shipment when stored properly .

• Buffer Composition: Most RPS18 antibodies are supplied in PBS with 0.02% sodium azide and 50% glycerol at pH 7.3 . This formulation helps maintain antibody stability during freeze-thaw cycles.

• Aliquoting Practices: For antibodies without BSA, prepare single-use aliquots upon receipt to minimize freeze-thaw cycles, though some formulations indicate that "aliquoting is unnecessary for -20°C storage" .

• Working Solution Preparation: When preparing working dilutions:

  • Use fresh, cold buffer

  • Prepare immediately before use

  • Do not store diluted antibody for extended periods

• Contamination Prevention: Use sterile technique when handling antibody solutions to prevent microbial contamination, which can degrade antibody performance.

• Transport Considerations: If transporting between labs, maintain cold chain using dry ice for shipping or insulated containers with freezer packs for short-distance transport.

How can RPS18 antibodies be utilized in studies of extraribosomal functions?

Beyond their canonical role in ribosome structure, ribosomal proteins like RPS18 have emerged as having important extraribosomal functions. To investigate these non-traditional roles:

• Subcellular Fractionation Combined with Immunoblotting: Separate cellular compartments (cytosol, nucleus, mitochondria, etc.) and use RPS18 antibodies to detect potential non-ribosomal pools of the protein.

• Proximity Labeling Approaches: Combine RPS18 antibodies with BioID or APEX2 proximity labeling to identify novel interaction partners outside the ribosome context.

• Stress Response Studies: Monitor RPS18 localization changes during various cellular stresses using immunofluorescence with validated antibodies at recommended concentrations (4 μg/ml) .

• DNA Damage Response: Investigate potential roles in DNA damage pathways through co-localization studies with DNA damage markers and RPS18 antibodies.

• Methodology for Non-Canonical Complex Isolation:

  • Use size exclusion chromatography to separate different RPS18-containing complexes

  • Follow with immunoprecipitation using RPS18 antibodies

  • Analyze isolated complexes by mass spectrometry to identify non-ribosomal interaction partners

This approach has revealed unexpected functions for several ribosomal proteins and may yield similar insights for RPS18.

What considerations exist when using RPS18 as an internal control or reference gene?

RPS18 is sometimes used as a housekeeping gene or loading control, but researchers should consider several important factors:

• Expression Stability Assessment: Before using RPS18 as a reference, validate its expression stability in your specific experimental conditions. Ribosomal proteins can be regulated under certain conditions, particularly:

  • Cellular stress responses

  • Growth factor stimulation

  • Viral infection (as noted in dengue virus studies)

• Methodological Approach for Validation:

  • Compare RPS18 with multiple alternative reference genes (GAPDH, β-actin, etc.)

  • Use algorithms like geNorm, NormFinder, or BestKeeper to assess expression stability

  • Perform preliminary experiments under your specific conditions to confirm stable expression

• Antibody Selection for Loading Control Applications:

  • Choose antibodies with demonstrated linearity across a wide range of protein concentrations

  • Validate with recombinant protein standards at known concentrations

  • Consider using direct detection methods (fluorescent secondary antibodies) for more accurate quantification

• Multiple Reference Approach: Rather than relying solely on RPS18, consider normalizing to multiple reference proteins to increase reliability of quantification.

By addressing these methodological considerations, researchers can effectively leverage RPS18 antibodies across a wide range of applications while ensuring robust and reproducible results.